Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

EGFR inhibitors can cause unusual localized hair growth.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Erlotinib can cause hair loss as a side effect.

Cetuximab can cause eyelash growth, which is rare but manageable.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Cancer treatments often cause skin, nail, and hair problems.

Gray hair can potentially be reversed, leading to new treatments.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Sesamin may help treat hair loss by affecting specific cell pathways.

Blocking IL-17a can improve age-related smell loss in mice.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Erlotinib can cause persistent excessive hair growth.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

The enzyme PA-PLA1α is important for proper hair follicle development.

EGFR signaling is essential for ear cell regeneration in both birds and mammals.

A genetic variant in "Blonde d'Aquitaine" calves causes death at birth due to a missing protein.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Piperonylic acid may help hair growth and treat hair loss.

EGFR helps control how hair grows and forms without needing p53 protein.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.